Beijing Shiqiao Biopharmaceutical Co., Ltd.-Shanghai Jiehao Biology Provides Fan Filter Delivery Window
Beijing Shiqiao Biopharmaceutical Co., Ltd-Shanghai jiehao biology provides fan filter transmission hatch
Shanghai Jiehao Biotechnology Co., Ltd., as a professional supplier of clean room equipment, successfully completed the supply of key equipment for Beijing Shiqiao Phase I and Phase II clean room projects. In this important project, Shanghai Jiehao provided advanced self-cleaning transfer window equipment, which played a vital role in ensuring the sterile transfer of the clean room environment.
As the general contractor of the project, CLP No.4 Company is responsible for the construction and management of the whole clean room project, which ensures the smooth progress and high standard completion of the project. Shanghai Jiehao's self-purification pass box provides a reliable sterile environment for the clean room of Beijing Shiqiao with its high-efficiency filtration and automatic control functions, meets the relevant requirements of GMP, and ensures product quality and operation safety.
Shanghai Jie Haoself-cleaning passbox has the following features:
-Tightness: to ensure that the ingress of contaminants is prevented during the transfer process.
-Air filtration: There is a high-efficiency air filter inside to keep the air clean.
-Automatic control: Equipped with an automatic control system to prevent two doors from opening at the same time, reducing the risk of cross-contamination.
-Ultraviolet disinfection: with ultraviolet lamp, disinfection of the transfer of goods.
-Easy to clean: The internal and external design is easy to clean and maintain equipment performance.
Through this cooperation, Shanghai Jiehao Biotechnology Co., Ltd. once again proved its leading position in the field of biosafety and clean room equipment, and made positive contributions to the development of the pharmaceutical industry. We look forward to more opportunities to cooperate with CLP IV in the future to jointly promote the progress of the industry.
Beijing Shiqiao Biopharmaceutical Co., Ltd. is a national high-tech enterprise established on April 10, 2002, focusing on the research and development, production and sales of drugs. The company is located in Shunyi District, Beijing, with an area of about 80000 square meters and a construction area of about 50000 square meters. The design of the factory focuses on environmental protection and sustainable development, and realizes the recycling of sewage treatment and the environmental protection of waste gas.
Shiqiao Biopharmaceutical's vision is to become a "leader in health industry innovation" and uphold the core values of "unity, innovation, excellence and win-win. The company has established extensive industry-university-research cooperation with many well-known scientific research institutions, such as Peking University, Tsinghua University, Beijing University of Chemical Technology, Institute of Materia Medica, Chinese Academy of Medical Sciences, etc., and jointly developed a number of national first-class new drugs with independent intellectual property rights., And more than 50 new drugs and high-end generic drugs. The company's product line covers nutrition, anti-tumor and controlled release drugs and other fields.
In addition, Shiqiao Biopharmaceutical also has a professional academic promotion team and a nationwide sales network to ensure that its products can cover a wide range of markets. The company has a subsidiary Sciecure Pharma in the United States to further expand its international market.
In terms of production facilities, Shiqiao Biopharmaceutical has a number of production lines that meet China's GMP, US FDA and EU GMP standards, including small-volume injections, lyophilized powder injections, large-volume injections, solid preparations and APIs. The company also launched the second phase of the project to expand the scale of production, the introduction of the world's advanced production equipment, and the use of the leading ERP, MES management system.
China Electronic System Engineering Fourth Construction Co., Ltd. (referred to as "CLP Fourth Company") was established in 1953 and is affiliated to China System (CESTC) under China Electronics (CEC), one of the world's top 500 companies. It is a company focusing on high-tech industrial engineering Comprehensive service provider in the field. The company's business covers engineering consulting, engineering design, engineering contracting, facility management and product manufacturing, especially in high-tech fields such as semiconductors, flat panel displays, biomedicine, chemical environmental protection, cloud computing and new energy.
CLP No. 4 Company enjoys a good social reputation at home and abroad, and has won many honors such as Luban Award, National Quality Engineering Award, China Installation Star, etc., and has been rated as "National Excellent Construction Enterprise" and "National AAA Credit Enterprise". The company attaches great importance to scientific and technological innovation, has a wealth of patents and standards, as well as a strong professional and technical team.
In the field of biomedical construction, CLP IV has demonstrated its strong strength and professional capabilities. The company has built and served projects of Pfizer, AstraZeneca, Qilu, Merck, Roche, Novartis and other well-known enterprises at home and abroad, reflecting its leading position and influence in the industry. In addition, CLP IV also actively participated in major national strategic projects, such as the construction of nearly 20 new coronary pneumonia vaccine production workshops for enterprises such as Beisheng Institute, Wusheng Institute, Beijing Kexing and Zhifei Bio during the new coronary pneumonia epidemic, making important contributions to the global fight against the epidemic.
CLP Fourth Company takes "domestic first-class engineering company" as its vision, adhering to the values of "truth-seeking, integrity, harmony, and diligence" and the business philosophy of "customer-oriented, service-leading", and is committed to providing customers with high-quality engineering services. Contribute more high-quality projects to the society, and make new and greater contributions to the prosperity and development of high-tech industries.
